Redhill Biopharma Ltd (NASDAQ:RDHL)
| 10.06 BATS BZX Real-Time Price As of 10:42am ET |  +0.02 / +0.20%Today’s Change | 3.26 Today|||52-Week Range 11.35 | +65.73% Year-to-Date |
Latest RDHL News | Press Releases
| RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib Sep 23 / Zacks.com - Paid Partner Content | RedHill's opaganib shows encouraging action against SARS-CoV-2 in preclinical study, shares up 12% Sep 08 / Seeking Alpha - Paid Partner Content |
| RedHill Biopharma (RDHL) Investor Presentation - Slideshow Sep 11 / Seeking Alpha - Paid Partner Content | RedHill Biopharma (RDHL) Investor Presentation - Slideshow Sep 04 / Seeking Alpha - Paid Partner Content |
| RedHill: Possibilities Abound Sep 11 / Seeking Alpha - Paid Partner Content | State of Pennsylvania grants RedHill's opaganib COVID-19 grant Sep 03 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 10.04 |
| Today’s open | 9.95 |
| Day’s range | 9.95 - 10.06 |
| Volume | 900 |
| Average volume (3 months) | 379,082 |
| Market cap | $372.2M |
Data as of 10:42am ET, 09/29/2020
Growth & Valuation
| Earnings growth (last year) | +14.59% |
| Earnings growth (this year) | +18.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.26% |
| P/E ratio | NM |
| Price/Sales | 28.56 |
| Price/Book | 5.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OVIDOvid Therapeutics In... | +0.12 | +2.04% |
| IDYAIDEAYA Biosciences I... | -0.89 | -7.26% |
| STROSutro Biopharma Inc | -0.05 | -0.49% |
| BDSIBioDelivery Sciences... | -0.05 | -1.46% |
Data as of 11:11am ET, 09/29/2020
Financials
| Next reporting date | November 16, 2020 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $6.3M |
| Annual profit (last year) | -$42.4M |
| Net profit margin | -672.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
